Back to Posters

Breast and ovarian cancer risks associated with cancer predisposition gene mutations identified by multigene panel testing.

Date:

Saturday, Apr 16, 2016 3:15pm – 5:10pm

Conference:

—

Authors:

David E. Goldgar, Elizabeth Chao, Emily Hallberg, Fergus Couch, Holly Laduca, Huong Meeks, Jill Dolinsky, Raymond Moore, Robert Huether, Steven N. Hart

Multigene panel testing (MGPT) for hereditary cancer is increasing in popularity in the USA. Many panels include genes identified as hereditary breast and/or ovarian cancer (HBOC) genes despite limited data regarding the precise cancer risks associated with mutations in these genes.